| ||||||||||||||
|
|
|||||||||||||
Post-Anesthesia Care Unit, Tel Aviv Sourasky Medical Center, and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Central N-methyl-D-aspartate receptors modulate postoperative pain. We compared the effects of preincision oral dextromethorphan (DM), an N-methyl-D-aspartate receptor antagonist, on postoperative IV patient-controlled analgesia morphine demand and on subjective variables in 80 patients undergoing lower-body procedures who were randomly assigned to epidural lidocaine (LA; 16 mL, 1.6%) or general anesthesia (GA). The patients were premedicated 90 min before surgery with placebo or DM 90 mg (20 patients per group) in a double-blinded manner. Postoperative IV patient-controlled analgesia morphine administration started when subjective pain intensity was
4 of 10 (visual analog scale) and lasted 2 h. Observation continued up to 3 days, during which patients could use diclofenac. LA-DM and GA-DM patients required 45%50% less morphine and diclofenac compared with their placebo counterparts (P < 0.001). However, GA-DM patients made twice as many attempts to self-administer morphine as LA-DM patients (P = 0.005). Eight LA-DM versus two GA-DM patients (P < 0.01) used no morphine or diclofenac. All DM patients experienced significantly (P < 0.001) less pain, were less sedated, and felt better than their placebo counterparts; however, compared with placebo, DM improved subjective scorings in the GA patients more significantly (P < 0.05) than in the LA patients. We conclude that oral DM 90 mg in patients undergoing surgery under LA or GA reduces morphine and diclofenac use by
50% in the immediate and late postoperative period compared with placebo. Subjectively scored levels of pain, sedation, and well-being were better as well.
This article has been cited by other articles:
![]() |
C.-C. Yeh, S.-W. Jao, B. K. Huh, C.-S. Wong, C.-P. Yang, W. D. White, and C.-T. Wu Preincisional Dextromethorphan Combined with Thoracic Epidural Anesthesia and Analgesia Improves Postoperative Pain and Bowel Function in Patients Undergoing Colonic Surgery Anesth. Analg., May 1, 2005; 100(5): 1384 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. L. McCartney, A. Sinha, and J. Katz A Qualitative Systematic Review of the Role of N-Methyl-D-Aspartate Receptor Antagonists in Preventive Analgesia Anesth. Analg., May 1, 2004; 98(5): 1385 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Weinbroum, B. Bender, A. Nirkin, S. Chazan, I. Meller, and Y. Kollender Dextromethorphan-Associated Epidural Patient-Controlled Analgesia Provides Better Pain- and Analgesics-Sparing Effects than Dextromethorphan-Associated Intravenous Patient-Controlled Analgesia After Bone-Malignancy Resection: A Randomized, Placebo-Controlled, Double-Blinded Study Anesth. Analg., March 1, 2004; 98(3): 714 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. A. Choi, A. P. Kliffer, and M. J. Douglas Dextromethorphan and intrathecal morphine for analgesia after Caesarean section under spinal anaesthesia Br. J. Anaesth., May 1, 2003; 90(5): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Abraham, N. Marouani, and A. A. Weinbroum Dextromethorphan Mitigates Phantom Pain in Cancer Amputees Ann. Surg. Oncol., April 1, 2003; 10(3): 268 - 274. [Abstract] [Full Text] [PDF] |
||||
|